Looking to see where vitiligo treatments can go next? We've got some answers. This week, we're joined by Dr. David Rosmarin as he dives into the knowledge gaps of vitiligo. Listen in as he discusses patient concerns, alternative treatments and how you can become involved in clinical trials. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com.

David Rosmarin, MD is a clinical investigator and Vice-Chair for Research and Education at Tufts Medical Center focusing on clinical trials for inflammatory disorders of the skin. For his training, Dr. Rosmarin went to medical school at NYU, dermatology residency at Boston University-Tufts Combined training program, and fellowship at Brigham and Women's Hospital. Dr. Rosmarin joined Tufts Medical Center in 2013 focusing as a clinical trial investigator for atopic dermatitis. In 2016, Dr. Rosmarin became the Director of the Clinical Trials Unit in the Department of Dermatology at Tufts Medical Center and Program Director of the Residency Program. Clinically Dr. Rosmarin is nationally recognized and serves as a referral for physicians with difficult to manage inflammatory diseases such as atopic dermatitis. Dr. Rosmarin educates medical students, residents, and research fellows.

Sponsored by: AbbVie Visit AbbVie Website for more information.